WO2005041941A3 - Valsartan containing formulation - Google Patents

Valsartan containing formulation Download PDF

Info

Publication number
WO2005041941A3
WO2005041941A3 PCT/CZ2004/000073 CZ2004000073W WO2005041941A3 WO 2005041941 A3 WO2005041941 A3 WO 2005041941A3 CZ 2004000073 W CZ2004000073 W CZ 2004000073W WO 2005041941 A3 WO2005041941 A3 WO 2005041941A3
Authority
WO
WIPO (PCT)
Prior art keywords
valsartan
containing formulation
valsartan containing
formulation
weight
Prior art date
Application number
PCT/CZ2004/000073
Other languages
French (fr)
Other versions
WO2005041941A2 (en
Inventor
Beata Vladovicova
Mikulas Lehock
Viera Kormanova
Viera Hubinova
Original Assignee
Zentiva As
Beata Vladovicova
Mikulas Lehock
Viera Kormanova
Viera Hubinova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20032984A external-priority patent/CZ20032984A3/en
Priority claimed from CZ20041020A external-priority patent/CZ297417B6/en
Application filed by Zentiva As, Beata Vladovicova, Mikulas Lehock, Viera Kormanova, Viera Hubinova filed Critical Zentiva As
Priority to SK5047-2005A priority Critical patent/SK50472005A3/en
Priority to EA200500973A priority patent/EA008063B1/en
Priority to EP04797393A priority patent/EP1680095A2/en
Publication of WO2005041941A2 publication Critical patent/WO2005041941A2/en
Publication of WO2005041941A3 publication Critical patent/WO2005041941A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical containing valsartan, optionally a combination of valsartan with hydrochlorothiazide, obtainable by direct tabletting, comprises a filler having a particle size of 10 to 1000 µm, preferably 50 to 400 mm, in amounts of 20 to 60, preferably 40 to 60% by weight, based on the total weight of the formulation.
PCT/CZ2004/000073 2003-11-03 2004-11-02 Valsartan containing formulation WO2005041941A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SK5047-2005A SK50472005A3 (en) 2003-11-03 2004-11-02 Tablet containing valsartan prepared via direct tabletting
EA200500973A EA008063B1 (en) 2003-11-03 2004-11-02 Valsartan containing formulation
EP04797393A EP1680095A2 (en) 2003-11-03 2004-11-02 Valsartan containing formulation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CZPV2003-2984 2003-11-03
CZ20032984A CZ20032984A3 (en) 2003-11-03 2003-11-03 Tablet containing valsartan produced by direct tabletting
CZPV2004-1020 2004-10-07
CZ20041020A CZ297417B6 (en) 2004-10-07 2004-10-07 Valsartan containing pharmaceutical composition

Publications (2)

Publication Number Publication Date
WO2005041941A2 WO2005041941A2 (en) 2005-05-12
WO2005041941A3 true WO2005041941A3 (en) 2006-04-20

Family

ID=34553093

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CZ2004/000073 WO2005041941A2 (en) 2003-11-03 2004-11-02 Valsartan containing formulation

Country Status (5)

Country Link
EP (1) EP1680095A2 (en)
EA (1) EA008063B1 (en)
PL (1) PL382044A1 (en)
SK (1) SK50472005A3 (en)
WO (1) WO2005041941A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200703568A1 (en) 2007-05-24 2008-07-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Valsartan formulations
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose
EP2405899A2 (en) 2009-03-11 2012-01-18 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Valsartan formulations
DE102011108762A1 (en) * 2011-07-28 2013-01-31 Stada Arzneimittel Ag A compressed solid pharmaceutical composition comprising amorphous particulate valsartan as an active ingredient
EP4295839A1 (en) 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049394A2 (en) * 1996-06-27 1997-12-31 Novartis Ag Sold oral dosage forms of valsartan
WO2000038676A1 (en) * 1998-12-23 2000-07-06 Novartis Ag Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049394A2 (en) * 1996-06-27 1997-12-31 Novartis Ag Sold oral dosage forms of valsartan
WO2000038676A1 (en) * 1998-12-23 2000-07-06 Novartis Ag Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SCHMIDT PC, CHRISTIN I: "Wirk- und Hilfsstoffe für Rezeptur, Defektur und Grossherstellung", 1999, WISSENSCHAFTLICHE VERLAGSGESELLSCHAFT MBH, STUTTGART, XP002336328 *

Also Published As

Publication number Publication date
SK50472005A3 (en) 2005-09-08
PL382044A1 (en) 2007-08-06
EA008063B1 (en) 2007-02-27
EP1680095A2 (en) 2006-07-19
WO2005041941A2 (en) 2005-05-12
EA200500973A1 (en) 2006-02-24

Similar Documents

Publication Publication Date Title
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
AU2003285193A1 (en) Aluminum phosphate compounds, compositions, materials and related composites.
AU2003241327A1 (en) Amidinylphenyl compounds and their use as fungicides
AU2003216934A1 (en) Benzoxazinone derivatives, the preparation and use thereof as medicaments
EP1930011A3 (en) Crystalline form of ibandronate sodium
IL220759A (en) 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo [4,5-d] pyrimidin-2-one compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
WO2006008614A3 (en) A synergistic insecticidal composition containing chloronicotynyle and pyrethroids compounds
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
WO2005065318A3 (en) Effervescent oral opiate dosage form
AU2003242731A1 (en) Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
WO2007071581A3 (en) Pharmaceutical formulation for producing rapidly disintegrating tablets
AU2003301410A1 (en) Polymeric materials for site specific delivery to the body
EP2497513B8 (en) Inhalator for powdery, in particular medical, substances
AU2002354054A1 (en) Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
WO2005084648A8 (en) Pharmaceutical compositions comprising candesartan cilexetil
WO2011110854A3 (en) The use of amisulpride as an anti-emetic
WO2007106723A3 (en) Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
WO2007017331A3 (en) Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin
PL394604A1 (en) Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition
WO2008056375A3 (en) Pharmaceutical formulations comprising valsartan
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
WO2005041941A3 (en) Valsartan containing formulation
AU2003267602A1 (en) Polymer compositions for administration to animals
AU2003205858A1 (en) "long"-"acting" injectable parasiticidal composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 50472005

Country of ref document: SK

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 382044

Country of ref document: PL

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 200500973

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 2004797393

Country of ref document: EP

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWP Wipo information: published in national office

Ref document number: 2004797393

Country of ref document: EP